G42 Healthcare, a leading health-tech company based in Abu Dhabi, said it has partnered with Seegene, a global biotechnology company specialising in molecular diagnostics, to offer fully equipped mobile diagnostics and testing laboratories across the Mena region.

 

The partnership will offer the innovative Seegene Mobile Station – a laboratory-on-wheels facility providing optimised molecular diagnosis and tests at any location to safeguard the health of communities.

 

The services will be on offer in all the GCC countries as well as Algeria, Morocco, Tunisia, Libya, Egypt, Sudan, Palestine, Jordan, Iraq, Iran, Lebanon, Pakistan, Syria and Yemen.

 

The Seegene Mobile Station conforms with the WHO guidelines of BioSafety Level-2 and offers automated testing with minimum supervision. 

 

It has all essential equipment, RT-PCR reagents, consumables, IT solutions, and technical support for diagnostic testing, is transportable by ship or land and can be made operational within few days.

 

On the new venture, Ashish Koshy, the CEO of G42 Healthcare, said: "We are proud to enter into a collaboration with Seegene which offers equitable access to healthcare anywhere in the Pan-Arab region. This is part of our joint efforts with international organisations to share our knowledge and expertise to future proof the health of nations."

 

"At G42 Healthcare, our commitment is to uphold patient health and reinforce our credentials as a transformation enabler in healthcare for the good of all humanity," he stated after signing the deal with James Park, Seegene Executive Director during the Medlab Middle East Exhibition, the largest medical laboratory exhibition and congress in the Middle East currently under way in Dubai.

 

"The mobile testing services will further augment our business portfolio across the Mena region and help in reaching out to various markets, ensuring swift detection, and allowing patients to benefit from the most informed decision possible, regardless of the location," he added.

 

Park said the Seegene Mobile Station will contribute to the development of innovative solutions to bring healthy life for everyone by creating a new diagnostic paradigm. It also includes an equipment room and an extraction room.

 

It encompasses a container with biosafety level-2 laboratory for the extraction room, collection device, instruments compatible with all Seegene assays, IT solution with Seegene Viewer, Reagent and Consumables, and technical support.

 

"It will offer the most innovative mobile molecular diagnostic, testing and laboratory services and is part of our commitment to supporting the healthcare community in combatting Covid-19 infections, with a broad portfolio of research and development tools and diagnostics," he noted.

 

"The all-in-one platform enables 2,000 tests per day including 225 pathogens in 10 different criteria and offers a streamlined automated work­flow from pre-extraction to data analysis," he added.-TradeArabia News Service